Although a devastating disease, there is hope for improved survival for patients with amyotrophic lateral sclerosis (ALS). Two disease-modifying therapies (DMTs), which slow the progression of the disease in addition to other interventions, have improved care for these patients. Additional agents and potentially curative gene therapies are under investigation.
|Original language||English (US)|
|Number of pages||4|
|Journal||Journal of Managed Care Medicine|
|State||Published - 2021|
ASJC Scopus subject areas
- Health Policy